- Home
- CORT vs MKTX Comparison
CORT vs MKTX Comparison
Compare CORT & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- MKTX
- Stock Information
- Founded
- CORT 1998
- MKTX 2000
- Country
- CORT United States
- MKTX United States
- Employees
- CORT N/A
- MKTX N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- MKTX Investment Bankers/Brokers/Service
- Sector
- CORT Health Care
- MKTX Finance
- Exchange
- CORT Nasdaq
- MKTX Nasdaq
- Market Cap
- CORT 7.1B
- MKTX 8.1B
- IPO Year
- CORT N/A
- MKTX 2004
- Fundamental
- Price
- CORT $72.14
- MKTX $218.09
- Analyst Decision
- CORT Strong Buy
- MKTX Buy
- Analyst Count
- CORT 4
- MKTX 9
- Target Price
- CORT $142.00
- MKTX $241.78
- AVG Volume (30 Days)
- CORT 1.4M
- MKTX 493.0K
- Earning Date
- CORT 05-05-2025
- MKTX 05-07-2025
- Dividend Yield
- CORT N/A
- MKTX 1.39%
- EPS Growth
- CORT 8.36
- MKTX N/A
- EPS
- CORT 1.14
- MKTX 5.76
- Revenue
- CORT $685,446,000.00
- MKTX $815,355,000.00
- Revenue This Year
- CORT $36.81
- MKTX $7.50
- Revenue Next Year
- CORT $32.00
- MKTX $10.21
- P/E Ratio
- CORT $63.13
- MKTX $37.83
- Revenue Growth
- CORT 30.93
- MKTX 7.33
- 52 Week Low
- CORT $25.35
- MKTX $186.84
- 52 Week High
- CORT $117.33
- MKTX $296.68
- Technical
- Relative Strength Index (RSI)
- CORT 53.35
- MKTX 46.32
- Support Level
- CORT $68.92
- MKTX $218.00
- Resistance Level
- CORT $75.41
- MKTX $232.84
- Average True Range (ATR)
- CORT 3.83
- MKTX 6.12
- MACD
- CORT -0.13
- MKTX -0.24
- Stochastic Oscillator
- CORT 61.25
- MKTX 14.89
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.